Stock-Based Compensation and Stock Awards (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Summary of RSA Activity

The Company’s RSA activity and related information is presented below:

	Restricted Stock			Weighted- average Grant Date Fair Value
Unvested at December 31, 2021		465,035		$	25.48
Granted		371,190			22.82
Vested		(221,964	)		26.80
Forfeited		(34,457	)		24.23
Unvested at December 31, 2022		579,804		$	23.34

Schedule of Valuation Assumptions

Assumptions used in the Monte Carlo simulation are as follows:

	2022		2021		2020
Grant date	October 28, 2022		October 28, 2021		October 28, 2020
Performance period	October 1, 2022 to September 30, 2025		October 1, 2021 to September 30, 2024		October 1, 2020 to September 30, 2023
Volatility	57.3%		56.1%		50.9%
Risk-free interest rate	4.4%		0.8%		0.2%
Grant date price	$	23.28	$	23.54	$	23.86

Summary of PSA Activity

The Company’s Performance Unit activity and related information is presented below:

	Number of Performance Units			Weighted Average Grant Date Fair Value Per Unit
Unvested balance at December 31, 2021		224,374		$	34.83
Granted		168,727			22.52
Forfeited		(61,281	)		45.46
Unvested balance at December 31, 2022		331,820		$	26.61

Schedule of DSA Activity

The Company’s DSA activity for the year ended December 31, 2022 is presented below:

	DSA Number of Shares			Weighted Average Grant Date Fair Value Per Share
Unvested balance at December 31, 2021		70,786		$	26.94
Granted		58,287			23.56
Vested		(57,138	)		26.12
Unvested balance at December 31, 2022		71,935		$	24.85

Schedule of Information for Stock Option Plans

Equity Compensation Plan Information

The following table summarizes information for equity compensation plans in effect as of December 31, 2022:

	Number of securities to be issued upon exercise of outstanding options, warrants and rights (1)		Weighted- average exercise price of outstanding options, warrants and rights (2)		Number of securities remaining available for future issuance under equity compensation plan
Plan category	(a)		(b)		(c)
Equity compensation plans approved by stockholders		331,820	$	26.61		1,046,110
Total		331,820	$	26.61		1,046,110

(1) Excludes 651,739 shares of unvested RSAs and DSAs, which were granted pursuant to the 2017 Plan and the 2004 Plan. Includes 331,820 unvested Performance Units shown at 100% level of performance achievement.

(2) The weighted average exercise price does not take into account 331,820 unvested Performance Units, which do not have an exercise price.